Add to ORKGTHESIS 9978Particulate vaccine adjuvants, including alum and biodegradable polymer microparticles, are strong activators of antigen-specific humoral immunity. These particulates enhance NLRP3 inflammasome activation, but they are limited in their ability to promote proinflammatory T cells responses. For diseases such as TB and malaria, promotion of strong Th1 responses is a prerequisite for effective vaccines but adjuvants that safely promote such responses with subunit vaccines are lacking
THESIS 8996Particulate vaccine adjuvants (PVA) have been used in vaccines both experimentally and cl...
Background: Designing inhaled vaccine formulations against respiratory pathogens like Streptococcusp...
Chitosan-based adjuvants combine effectiveness, safety and economic feasibility and thus are quite p...
Chitosan (CS) is a natural polymer derived from chitin that has wide applications in drugs, vaccines...
The introduction of vaccines is regarded as one of the most successful medical interventions to date...
The advantage of mucosal vaccination is the induction of an immune response at entry sites of pathog...
Vaccines have been a tremendous breakthrough by preventing illness and death due to infectious disea...
With the support of modern biotechnology, vaccine technology continues to iterate. The safety and ef...
In this work we have established the efficient mucosal delivery of vaccines using absorption enhance...
THESIS 7961The development of new and improved vaccine formulations for human use requires the disco...
We used TSA as a principal antigen of Leishmania major with adjuvants. The aim of this research was ...
The cationic polysaccharide chitosan is an attractive candidate adjuvant capable of driving potent c...
Mucosal vaccination is a promising alternative to classical parental vaccination, as it is non-invas...
The recent advances in controlled delivery systems for protein pharmaceuticals such as microspheres,...
The most successful medical intervention for preventing infectious diseases is still vaccination. Th...
THESIS 8996Particulate vaccine adjuvants (PVA) have been used in vaccines both experimentally and cl...
Background: Designing inhaled vaccine formulations against respiratory pathogens like Streptococcusp...
Chitosan-based adjuvants combine effectiveness, safety and economic feasibility and thus are quite p...
Chitosan (CS) is a natural polymer derived from chitin that has wide applications in drugs, vaccines...
The introduction of vaccines is regarded as one of the most successful medical interventions to date...
The advantage of mucosal vaccination is the induction of an immune response at entry sites of pathog...
Vaccines have been a tremendous breakthrough by preventing illness and death due to infectious disea...
With the support of modern biotechnology, vaccine technology continues to iterate. The safety and ef...
In this work we have established the efficient mucosal delivery of vaccines using absorption enhance...
THESIS 7961The development of new and improved vaccine formulations for human use requires the disco...
We used TSA as a principal antigen of Leishmania major with adjuvants. The aim of this research was ...
The cationic polysaccharide chitosan is an attractive candidate adjuvant capable of driving potent c...
Mucosal vaccination is a promising alternative to classical parental vaccination, as it is non-invas...
The recent advances in controlled delivery systems for protein pharmaceuticals such as microspheres,...
The most successful medical intervention for preventing infectious diseases is still vaccination. Th...
THESIS 8996Particulate vaccine adjuvants (PVA) have been used in vaccines both experimentally and cl...
Background: Designing inhaled vaccine formulations against respiratory pathogens like Streptococcusp...
Chitosan-based adjuvants combine effectiveness, safety and economic feasibility and thus are quite p...